The effect of somatostatin analog octreotide (Sandostatin®) on luteinizing hormone and ovarian steroids in insulin-dependent diabetic women without residual insulin secretion.

Autor: Prelevićć, G. M., Wurzburger, M. I., Balint-Perićć, L.
Zdroj: Gynecological Endocrinology; 1992, Vol. 6 Issue 4, p259-263, 5p
Databáze: Complementary Index